Ruxolitinib Plus Decitabine Effectively Treats Myelodysplastic Syndrome/Myeloproliferative Neoplasm, Unclassifiable, by Decreasing the Variant Allele Frequency of KRAS

Myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable (MDS/MPN-U) is a subtype of MDS/MPN that exhibits a combination of the features of both MDS and MPN. To date, no curative treatment is available for MDS/MPN-U; however, previous studies have suggested a potential survival advantage...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Shuna, Xu, Xiaofei, Ye, Xingnong, Zhu, Xiaoqiong, Wu, Cai, Chen, Dan, Jin, Jingxia, Zheng, Yan, Zheng, Mengli, Huang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553600/
https://www.ncbi.nlm.nih.gov/pubmed/33116596
http://dx.doi.org/10.2147/OTT.S272207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553600/
https://www.ncbi.nlm.nih.gov/pubmed/33116596
http://dx.doi.org/10.2147/OTT.S272207

Ejemplares similares